sales@businessmarketinsights.com     UK: +442081254005
   

South and Central America Clinical Trials Supplies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product & Service (Manufacturing, Packaging & Labelling, and Logistics & Distribution), Stage (Phase I, Phase II, Phase III, and Bioequivalence Studies), Drug Type (Small-Molecule Drugs and Biologic Drugs), and Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Respiratory Disorders, and Others)

Code: TIPRE00022068 | Pages: 122 | Industry: Pharmaceuticals | Date: May 2021
Covid

Market Introduction

The clinical trial is an investigation study that defines whether a medical approach, therapy, or device is effective, safe, and useful for human applications. These studies help to find which therapeutic approaches experiment is best for certain diseases. Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance.

 

Market Overview and Dynamics

The South and Central America clinical trial supplies market is expected to reach US$ 164.29 million by 2027 from US$ 99.61 million in 2019; it is estimated to grow at a CAGR of 6.5% from 2020 to 2027. The growth of the market is attributed to some key driving factors such as increase in R&D expenditures by the pharmaceutical & biopharmaceutical companies, rise in number of clinical trials, and higher costs of drug development in developed nations. However, challenges for clinical trials due to the negative impact of COVID-19 pandemic are expected to restrain the growth of the market during the forecast years.

The clinical trial is an investigational study that defines whether a medical approach, therapy, or device is effective, safe, and useful for human applications. These studies help to find which therapeutic approach is best for certain diseases. Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance. Research and development (R&D) is a significant and essential part of the business of pharmaceuticals and biopharmaceuticals companies. R&D spending by biopharmaceuticals companies has increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of these companies has increased from US$ 59.6 billion in 2015 to US$ 79.6 billion in 2018. Drug development and discovery is a time-consuming and expensive process. The process stages range from early detection or design to development and regulatory approval, and the entire process can take more than 10–15 years. Throughout the drug development phase, various testing services are required to check the quality and efficacy of the drug substance. Several manufacturers are investing in clinical supplies in the pharmaceutical industry. Therefore, the pharmaceutical and biotech companies are dependent on the supplies for the services to the clinical trials, which is expected to drive the market. Also, advanced health care infrastructure, and presence of multinational pharmaceutical and biotechnology companies that carry out clinical trials in South and Central America will bolster the market growth.

Since the surge of COVID-19 cases, the pharmaceutical industry is facing a decrease in production capabilities, resulting in drug shortages. Moreover, diversion of resources from drug development to coronavirus treatment is likely to hamper overall productivity of the drug development for a short period of span. Various pharmaceutical companies made decisions to postpone the ongoing clinical trials due to disrupted supply chains and threat of the virus. However, the procedures and practices have now re-initiated due to economic losses in the commercial sectors of South and Central America. Thus, the COVID-19 pandemic had a positive as well as negative impact on the South and Central America clinical trial supplies market.

 

Key Market Segments

Based on product & service, the South and Central America clinical trial supplies market is segmented into manufacturing, packaging & labelling, and logistics & distribution. The logistics & distribution segment held the largest share of the market in 2019; the same segment is anticipated to register the highest CAGR in the market during the forecast period.

In terms of stage, the South and Central America clinical trial supplies market is segmented into phase I, phase II, phase III, and bioequivalence studies. The phase III segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

Based on drug type, the South and Central America clinical trial supplies market is segmented into small-molecule drugs and biologic drugs. The small-molecule drugs segment held the largest share of the market in 2019, whereas the biologic drugs segment is estimated to register the highest CAGR in the market during the forecast period.

In terms of application, the South and Central America clinical trial supplies market has been segmented into oncology, cardiovascular diseases, neurological disorders, respiratory disorders, and others. The oncology segment held the largest share of the market in 2019 and is estimated to register the highest CAGR during the forecast period.

 

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the South and Central America clinical trial supplies market are the Ministry of Health and Prevention (MoHAP), Pharmaceutical Research and Manufacturers of America (PhRMA) and Association of Clinical Research Organizations (ACRO).

 

Reasons to buy the report

  • Determine prospective investment areas based on a detailed trend analysis South and Central America clinical trial supplies market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the South and Central America clinical trial supplies market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the South and Central America clinical trial supplies market.

 

SOUTH AND CENTRAL AMERICA CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION

By Product & Service

  • Manufacturing
  • Packaging & Labelling
  • Logistics & Distribution

By Stage

  • Phase I
  • Phase II
  • Phase III
  • Bioequivalence Studies

By Drug Type

  • Small-molecule Drugs
  • Biologic Drugs

By Application

  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Respiratory Disorders
  • Others

By Country

  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

  • THERMO FISHER SCIENTIFIC INC.
  • UDG Healthcare plc
  • Catalent Inc.
  • PAREXEL INTERNATIONAL CORPORATION
  • Biocair
  • Owens & Minor Inc

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South and Central America Clinical Trial Supplies Market – By Product & Service

1.3.2        South and Central America Clinical Trial Supplies Market – By Stage

1.3.3        South and Central America Clinical Trial Supplies Market – By Drug Type

1.3.4        South and Central America Clinical Trial Supplies Market – By Application

1.3.5        South and Central America Clinical Trial Supplies Market – By Country

2.           Clinical Trial Supplies Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Clinical Trial Supplies – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South and Central America – PEST Analysis

4.3         Expert Opinion

5.           Clinical Trial Supplies – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Pharmaceutical and Biopharmaceutical R&D Expenditures

5.1.2        Higher Cost of Drug Development Process in Developed Countries

5.2         Market Restraints

5.2.1        Rising Cost of Drug Development and Clinical Trials

5.2.2        Challenges for Clinical Trials Due to Negative Impact of Corona Virus

5.3         Key Market Opportunities

5.3.1        Growing Opportunities in Developing Nations

5.4         Future Trends

5.4.1        Growing Biosimilars and Biologics Market

5.5         Impact analysis

6.           Clinical Trial Supplies Market – South and Central America Analysis

6.1         South and Central America Clinical Trial Supplies Market Revenue Forecast and Analysis

7.           Clinical Trial Supplies Market Analysis – By Product and Service

7.1         Overview

7.2         Clinical Trial Supplies Market Revenue Share, by Product and Service (2019 and 2027)

7.3         Logistics & Distribution

7.3.1        Overview

7.3.2        Logistics & Distribution: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Manufacturing

7.4.1        Overview

7.4.2        Manufacturing: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Packaging & Labelling

7.5.1        Overview

7.5.2        Packaging & Labelling: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

8.           Clinical Trial Supplies Market – By Stage

8.1         Overview

8.2         Clinical Trial Supplies Market, by Stage, 2019 and 2027 (%)

8.3         Phase III

8.3.1        Overview

8.3.2        Phase III: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Phase II

8.4.1        Overview

8.4.2        Phase II: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Bioequivalence Studies

8.5.1        Overview

8.5.2        Bioequivalence Studies: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

8.6         Phase I

8.6.1        Overview

8.6.2        Phase I: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

9.           Clinical Trial Supplies Market – By Drug Type

9.1         Overview

9.2         Clinical Trial Supplies Market, by Drug Type 2019 and 2027 (%)

9.3         Small-molecule Drugs

9.3.1        Overview

9.3.2        Small-molecule Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Biologic Drugs

9.4.1        Overview

9.4.2        Biologic Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.        Clinical Trial Supplies Market – By Application

10.1      Overview

10.2      Clinical Trial Supplies Market, by Application 2019 and 2027 (%)

10.3      Oncology

10.3.1     Overview

10.3.2     Oncology: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.4      Cardiovascular Diseases

10.4.1     Overview

10.4.2     Cardiovascular Diseases: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.5      Neurological Disorders

10.5.1     Overview

10.5.2     Neurological Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.6      Respiratory Disorders

10.6.1     Overview

10.6.2     Respiratory Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.7      Others

10.7.1     Overview

10.7.2     Others: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.        Clinical Trial Supplies Market – South and Central America Analysis

11.1      South and Central America: Clinical Trial Supplies Market

11.1.1     Overview

11.1.2     South and Central America: Clinical Trial Supplies Market, by Country, 2018 & 2027 (%)

11.1.3     Brazil: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.1       Brazil: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.2       Brazil: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)

11.1.3.3       Brazil: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)

11.1.3.4       Brazil: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)

11.1.3.5       Brazil: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)

11.1.4     Argentina: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.4.1       Argentina: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.4.2       Argentina: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)

11.1.4.3       Argentina: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)

11.1.4.4       Argentina: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)

11.1.4.5       Argentina: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)

12.        Impact of COVID-19 Pandemic on South and Central America Clinical Trial Supplies Market

12.1      South and Central America: Impact Assessment of COVID-19 Pandemic

13.        Clinical Trials Supplies Market – Industry Landscape

13.1      Overview

13.2      Organic Developments

13.2.1     Overview

13.3      Inorganic Developments

13.3.1     Overview

14.        Clinical Trial Supplies Market – Key Company Profiles

14.1      THERMO FISHER SCIENTIFIC INC.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      UDG Healthcare plc

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Catalent Inc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      PAREXEL INTERNATIONAL CORPORATION

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Biocair

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Owens & Minor Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

15.        Appendix

15.1      About the Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             Brazil Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 2.             Brazil Clinical Trials Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)

Table 3.             Brazil Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             Brazil Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             Argentina Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 6.             Argentina Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)

Table 7.             Argentina Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Argentina Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.             Organic Developments Done by Companies

Table 10.          Inorganic Developments Done by Companies

Table 11.          Glossary of Terms, Clinical Trial Supplies Market

 

LIST OF FIGURES

Figure 1.           Clinical Trial Supplies Market Segmentation

Figure 2.           Clinical Trial Supplies Segmentation, By Country

Figure 3.           South and Central America Clinical Trial Supplies Market Overview

Figure 4.           Logistics & Distribution Segment Held Largest Share of Product & Service Segment in Clinical Trial Supplies Market

Figure 5.           Phase III Segment Held Largest Share of Stage Segment in Clinical Trial Supplies Market

Figure 6.           Small-molecule Drugs Segment Held Largest Share of Drug type Segment in Clinical Trial Supplies Market

Figure 7.           Oncology Segment Held Largest Share of Application Segment in Clinical Trial Supplies Market

Figure 8.           Brazil Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 9.           South and Central America PEST Analysis

Figure 10.        Clinical Trial Supplies Market Impact Analysis of Drivers and Restraints

Figure 11.        South and Central America Clinical Trial Supplies Market – Revenue Forecast and Analysis – 2019- 2027

Figure 12.        Clinical Trial Supplies Market Revenue Share, by Product and Service (2019 and 2027)

Figure 13.        Logistics & Distribution: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Manufacturing: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Packaging & Labelling: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Clinical Trial Supplies Market, by Stage 2019 and 2027 (%)

Figure 17.        Phase III: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Phase II: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Bioequivalence Studies: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Phase I: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Clinical Trial Supplies Market, by Drug Type, 2019 and 2027 (%)

Figure 22.        Small-molecule Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Biologics Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Clinical Trial Supplies Market, by Application, 2019 and 2027 (%)

Figure 25.        Oncology: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Cardiovascular Diseases: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Neurological Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Respiratory Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Others: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        South and Central America: Clinical Trial Supplies Market, by Key Country – Revenue (2019) (USD Million)

Figure 31.        South and Central America: Clinical Trial Supplies Market, by Country, 2018 & 2027 (%)

Figure 32.        Brazil: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.        Argentina: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        Impact Of COVID-19 Pandemic in South and Central America Market

 

  1. THERMO FISHER SCIENTIFIC INC.
  2. UDG Healthcare plc
  3. Catalent Inc.
  4. pci Pharma Services
  5. PAREXEL INTERNATIONAL CORPORATION
  6. Biocair
  7. Owens & Minor Inc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America clinical trial supplies market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South and Central America clinical trial supplies market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

 


Related Tags South and Central America Clinical Trials Supplies Market South and Central America Clinical Trials Supplies Market Research South and Central America Clinical Trials Supplies Market Insight South and Central America Clinical Trials Supplies Market Trends South and Central America Clinical Trials Supplies Market Forecast South and Central America Clinical Trials Supplies Market Share South and Central America Clinical Trials Supplies Market 2027 South and Central America Clinical Trials Supplies Market Growth South and Central America Clinical Trials Supplies Industry Sector South and Central America Clinical Trials Supplies PDF Report South and Central America Clinical Trials Supplies Analysis South and Central America Clinical Trials Supplies Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000